CM
RMD icon

Capula Management’s ResMed RMD Stock Holding History

Capula Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Hold
100
– – ﹤0.01% 663
2026
Q1 		$22.4K Hold
100
– – ﹤0.01% 1037
2025
Q4 		$24.1K Hold
100
– – ﹤0.01% 788
2025
Q3 		$27.4K Buy
+100
New +$27.3K ﹤0.01% 776

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capula Management's RMD Position: Q2 2026 in Review

Capula Management increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $45.6K and bringing the position to 1,523 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Capula Management first reported a position in RMD in Q3 2021 and has held it in 8 quarters since. The position peaked at $494K in Q2 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Capula Management held 1,523 shares of ResMed worth $297K as of Q2 2026.
  • Capula Management bought 220 ResMed shares in Q2 2026, an estimated $45.6K.
  • ResMed made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #480 holding.
  • Capula Management first reported a position in ResMed in Q3 2021 and has held it in 8 quarters since.
  • Capula Management's ResMed position peaked at $494K in Q2 2023.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.